A Non Interventional Study With Paclitaxel Onkovis (Paclitaxel) Utilized for the Treatment of Cancer

Onkovis

Status: Completed

Conditions: Carcinoma

Study type: Observational

Funder types: Industry

Identifiers

NCT01668108

ONKOPAC 01

Details and patient eligibility

About

The main purpose of this observational study with Paclitaxel is to determine the number of treatment cycles and the quantity of Paclitaxel onkovis needed therefore under the special circumstance of ambulant chemotherapy.

onkovis aims an economical utilization of the chemotherapeutics.The provision with adapted packaging sizes as to decrease the excess quantity to be discarded follows also this objective.

Secondary objectives are the survey of the side effects of Paclitaxel onkovis in comparison to Docetaxel. To this purpose, data regarding co medications and adverse events are also collected.

Enrollment: 770 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Indication for Paclitaxel according to the SmPC and treating physician

Exclusion criteria

• according to the Paclitaxel SmPC

Trial design

770 participants in 1 patient group

carcinoma, Paclitaxel onkovis (Paclitaxel)

Description:

treatment in mono- or combination therapy with Paclitaxel of breast-, non-small cell lung- and ovarial cancer.